| Abstract |
Hung-Fat Tse, Chu-Pak Lau
From Cardiology Division, Department of Medicine, The University of Hong Kong,
Queen Mary Hospital, Hong Kong
TSE and LAU: Update on Therapeutic Myocardial Angiogenesis. Recent advances in the understanding of the mechanisms of neovascularization and the identification of potent angiogenic growth factors have led to the development of therapeutic angiogenesis for treatment of severe ischemic heart disease. Current clinical studies on therapeutic myocardial angiogenesis generally involved the delivery of recombinant protein or gene of the angiogenic growth factors using various different approaches. Although the initial clinical results are encouraging, the potential side effects of these potent angiogenic growth factors remain a major concern. Large-scale, randomized and placebo control studies will be required to demonstrate the clinical benefit of this novel therapeutic treatment of ischemic heart disease. (J HK Coll Cardiol 2002;10:81-87)
Key words : Ischemic heart disease, therapeutic angiogenesis